Delving into the Latest Updates on Rukangshu Capsule with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Urogenital Diseases

Active Indication

Uterine Hemorrhage

Inactive Indication-

Originator Organization

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Active Organization

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhaseApproved

First Approval Date

China (10 Dec 2018),

Uterine Hemorrhage

Regulation-

Login to view timeline

在广泛应用条件下，评价乳康舒胶囊治疗乳腺增生病（肾虚肝郁、冲任失调）的安全性和有效性。1.扩大年龄范围，观察乳康舒胶囊临床应用的安全性和有效性。2.观察乳康舒胶囊辨病用药的安全性和有效性。3.增加适应亚型，观察乳康舒胶囊对乳痛症的安全性和有效性。4.延长疗程，观察乳康舒胶囊临床应用的安全性和有效性。

[Translation]

Under the condition of wide application, evaluate the safety and effectiveness of Rukangshu capsule in treating breast hyperplasia (kidney deficiency, liver depression, Chong and Ren disorders). 1. Expand the age range and observe the safety and effectiveness of Rukangshu capsule in clinical application. 2. Observe the safety and effectiveness of Rukangshu capsule in disease differentiation and medication. 3. Add the subtype of application and observe the safety and effectiveness of Rukangshu capsule in mastalgia. 4. Extend the course of treatment and observe the safety and effectiveness of Rukangshu capsule in clinical application.

Start Date30 Dec 2013

Sponsor / Collaborator

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

[+1]

100 Clinical Results associated with Rukangshu Capsule

Login to view more data

100 Translational Medicine associated with Rukangshu Capsule

Login to view more data

100 Patents (Medical) associated with Rukangshu Capsule

Login to view more data

100 Deals associated with Rukangshu Capsule

Login to view more data